Wells Fargo’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $814M | Sell |
6,439,586
-188,855
| -3% | -$24.9M | 0.13% | 145 |
|
|
2026
Q1 | $924M | Sell |
6,628,441
-20,734
| -0.3% | -$2.9M | 0.17% | 121 |
|
|
2025
Q4 | $816M | Buy |
6,649,175
+197,161
| +3% | +$24M | 0.15% | 128 |
|
|
2025
Q3 | $716M | Sell |
6,452,014
-1,174
| -0% | -$133K | 0.14% | 142 |
|
|
2025
Q2 | $715M | Sell |
6,453,188
-79,840
| -1% | -$8.5M | 0.15% | 137 |
|
|
2025
Q1 | $732M | Sell |
6,533,028
-281,784
| -4% | -$29.1M | 0.17% | 125 |
|
|
2024
Q4 | $629M | Sell |
6,814,812
-377,656
| -5% | -$34M | 0.14% | 143 |
|
|
2024
Q3 | $603M | Sell |
7,192,468
-115,677
| -2% | -$8.83M | 0.14% | 146 |
|
|
2024
Q2 | $501M | Buy |
7,308,145
+240,922
| +3% | +$16.1M | 0.12% | 161 |
|
|
2024
Q1 | $518M | Sell |
7,067,223
-55,319
| -0.8% | -$4.25M | 0.12% | 158 |
|
|
2023
Q4 | $577M | Buy |
7,122,542
+89,291
| +1% | +$6.95M | 0.15% | 139 |
|
|
2023
Q3 | $527M | Sell |
7,033,251
-193,608
| -3% | -$14.9M | 0.15% | 142 |
|
|
2023
Q2 | $557M | Sell |
7,226,859
-374,655
| -5% | -$29.9M | 0.15% | 141 |
|
|
2023
Q1 | $631M | Sell |
7,601,514
-590,186
| -7% | -$48.9M | 0.18% | 123 |
|
|
2022
Q4 | $703M | Sell |
8,191,700
-337,231
| -4% | -$26.7M | 0.21% | 111 |
|
|
2022
Q3 | $526M | Sell |
8,528,931
-7,608
| -0.1% | -$480K | 0.17% | 131 |
|
|
2022
Q2 | $528M | Sell |
8,536,539
-188,780
| -2% | -$11.7M | 0.16% | 135 |
|
|
2022
Q1 | $519M | Buy |
8,725,319
+1,387,944
| +19% | +$88.7M | 0.13% | 151 |
|
|
2021
Q4 | $533M | Sell |
7,337,375
-1,855,401
| -20% | -$128M | 0.13% | 156 |
|
|
2021
Q3 | $642M | Sell |
9,192,776
-141,647
| -2% | -$9.95M | 0.14% | 141 |
|
|
2021
Q2 | $643M | Buy |
9,334,423
+241,028
| +3% | +$16.1M | 0.14% | 150 |
|
|
2021
Q1 | $588M | Sell |
9,093,395
-279,783
| -3% | -$18M | 0.13% | 159 |
|
|
2020
Q4 | $546M | Buy |
9,373,178
+720,822
| +8% | +$43.5M | 0.13% | 156 |
|
|
2020
Q3 | $547M | Buy |
8,652,356
+1,670,049
| +24% | +$116M | 0.15% | 145 |
|
|
2020
Q2 | $537M | Sell |
6,982,307
-2,419,144
| -26% | -$185M | 0.16% | 144 |
|
|
2020
Q1 | $703M | Buy |
9,401,451
+391,865
| +4% | +$27.1M | 0.24% | 92 |
|
|
2019
Q4 | $585M | Sell |
9,009,586
-881,241
| -9% | -$57.4M | 0.16% | 137 |
|
|
2019
Q3 | $627M | Buy |
9,890,827
+370,351
| +4% | +$24.2M | 0.18% | 125 |
|
|
2019
Q2 | $643M | Buy |
9,520,476
+228,966
| +2% | +$15.1M | 0.18% | 121 |
|
|
2019
Q1 | $604M | Buy |
9,291,510
+206,038
| +2% | +$13.7M | 0.18% | 127 |
|
|
2018
Q4 | $568M | Buy |
9,085,472
+72,533
| +0.8% | +$5.07M | 0.19% | 121 |
|
|
2018
Q3 | $696M | Buy |
9,012,939
+668,483
| +8% | +$50.5M | 0.2% | 113 |
|
|
2018
Q2 | $591M | Sell |
8,344,456
-1,654,930
| -17% | -$117M | 0.18% | 125 |
|
|
2018
Q1 | $754M | Sell |
9,999,386
-1,170,721
| -10% | -$93.1M | 0.22% | 96 |
|
|
2017
Q4 | $800M | Sell |
11,170,107
-390,419
| -3% | -$29.6M | 0.23% | 89 |
|
|
2017
Q3 | $937M | Buy |
11,560,526
+229,896
| +2% | +$17.6M | 0.29% | 70 |
|
|
2017
Q2 | $802M | Sell |
11,330,630
-412,206
| -4% | -$27.4M | 0.26% | 81 |
|
|
2017
Q1 | $798M | Buy |
11,742,836
+436,746
| +4% | +$30.7M | 0.26% | 76 |
|
|
2016
Q4 | $810M | Sell |
11,306,090
-1,620,749
| -13% | -$120M | 0.29% | 70 |
|
|
2016
Q3 | $1.02B | Buy |
12,926,839
+1,300,169
| +11% | +$106M | 0.38% | 45 |
|
|
2016
Q2 | $970M | Sell |
11,626,670
-837,064
| -7% | -$74.3M | 0.38% | 49 |
|
|
2016
Q1 | $1.14B | Sell |
12,463,734
-375,496
| -3% | -$33.9M | 0.46% | 31 |
|
|
2015
Q4 | $1.3B | Sell |
12,839,230
-2,066,621
| -14% | -$215M | 0.51% | 24 |
|
|
2015
Q3 | $1.46B | Buy |
14,905,851
+1,335,027
| +10% | +$148M | 0.61% | 18 |
|
|
2015
Q2 | $1.59B | Sell |
13,570,824
-1,107,292
| -8% | -$121M | 0.61% | 16 |
|
|
2015
Q1 | $1.44B | Sell |
14,678,116
-127,884
| -0.9% | -$13M | 0.56% | 19 |
|
|
2014
Q4 | $1.4B | Buy |
14,806,000
+794,326
| +6% | +$82.2M | 0.55% | 24 |
|
|
2014
Q3 | $1.49B | Sell |
14,011,674
-470,841
| -3% | -$46.1M | 0.62% | 18 |
|
|
2014
Q2 | $1.2B | Sell |
14,482,515
-1,952,040
| -12% | -$152M | 0.49% | 25 |
|
|
2014
Q1 | $1.16B | Sell |
16,434,555
-626,269
| -4% | -$49.1M | 0.5% | 24 |
|
|
2013
Q4 | $1.28B | Buy |
17,060,824
+501,642
| +3% | +$34.9M | 0.56% | 22 |
|
|
2013
Q3 | $1.04B | Sell |
16,559,182
-226,188
| -1% | -$13.5M | 0.49% | 26 |
|
|
2013
Q2 | $861M | Buy |
+16,785,370
| New | +$875M | 0.45% | 30 |
|
Other funds holding GILD
Wells Fargo's GILD Position: Q2 2026 in Review
Wells Fargo reduced its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, selling an estimated $24.9M and leaving 6,439,586 shares worth $814M. The position accounts for 0.13% of the portfolio, ranked #145.
Wells Fargo first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.59B in Q2 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Wells Fargo held 6,439,586 shares of Gilead Sciences worth $814M as of Q2 2026.
- Wells Fargo sold 188,855 Gilead Sciences shares in Q2 2026, an estimated $24.9M.
- Gilead Sciences made up 0.13% of Wells Fargo's portfolio in Q2 2026, its #145 holding.
- Wells Fargo first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Wells Fargo's Gilead Sciences position peaked at $1.59B in Q2 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.